The role of nonacid reflux in NERD: Lessons learned from impedance-pH monitoring in 150 patients off therapy

American Journal of Gastroenterology

Volumn 103, Issue 11, 2008, Pages 2685-2693

  Savarino, Edoardo ^a   Zentilin, Patrizia ^a   Tutuian, Radu ^d   Pohl, Daniel ^d   Casa, Domenico D ^b   Frazzoni, Marzio ^c   Cestari, Renzo ^b   Savarino, Vincenzo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c Nuovo Ospedale S Agostino   (Italy)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; IMPEDANCE; MAJOR CLINICAL STUDY; MALE; NONEROSIVE REFLUX DISEASE; PATIENT MONITORING; PH; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 55349114697     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.02119.x     Document Type: Article

References (48)

1. Kahrilas PJ. Gastroesophageal reflux disease. JAMA 1996 276 : 983 8.
2. Spechler SJ. Epidemiology and natural history of gastroesophageal reflux disease. Digestion 1992 51 (Suppl 1 24 9.
3. Lagergren J, Bergestrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999 340 : 825 31.
4. Smout AJPM. Endoscopy-negative acid reflux disease. Aliment Pharmacol Ther 1997 11 (Suppl 2 81 5.
5. Lind T, Havelund T, Carlsson R, et al. Heartburn without esophagitis: Efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997 32 : 974 9.
6. Fass R, Fennerty MB, Vakil N. Non-erosive reflux disease (NERD) - current concepts and dilemmas. Am J Gastroenterol 2001 96 : 303 14.
7. Watson RGP, Tham TCK, Johnston BT, et al. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux - the "sensitive oesophagus". Gut 1997 40 : 587 90.
8. Johnston BT, Lewis SA, Collins JSA, et al. Acid perception in gastro-oesophageal reflux disease is dependent on psychological factors. Scand J Gastroenterol 1997 32 : 974 9.
9. Clouse RE, Richter JE, Heading RC, et al. Functional esophageal disorders. Gut 1999 45 (Suppl 2 II31 6.
10. Galmiche JP, Clouse RE, Balint A, et al. Functional esophageal disorders. Gastroenterology 2006 130 : 1459 65.
11. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 1997 92 : 1997 2000.
12. Fass R, Ofman JJ, Gralnek IM, et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 1999 159 : 2161 8.
13. Johnsson F, Weywadt L, Solhaug JH, et al. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol 1997 33 : 15 20.
14. Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid exposure on mechano-sensitivity and chemo-sensitivity in humans. Gastroenterology 1998 115 : 1363 73.
15. Sifrim D, Silny J, Holloway RH, et al. Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation: A study using intraluminal electrical impedance. Gut 1999 44 : 47 54.
16. Silny J. Intraluminal multiple electrical impedance procedure for measurement of gastrointestinal motility. J Gastrointest Motil 1991 3 : 151 62.
17. Silny J, Knigge KP, Fass J, et al. Verification of the intraluminal multiple electrical impedance measurement for the recording of gastrointestinal motility. J Gastrointest Motil 1993 5 : 107 22.
18. Fass J, Silny J, Braun J, et al. Measuring esophageal motility with a new intraluminal impedance device. First clinical results in reflux patients. Scand J Gastroenterol 1994 29 : 693 702.
19. Skopnik H, Silny J, Heiber O, et al. Gastroesophageal reflux in infants: Evaluation of a new intraluminal impedance technique. J Pediatr Gastroenterol Nutr 1996 23 : 591 8.
20. Sifrim D, Holloway RH, Silny J, et al. Composition of the postprandial refluxate in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001 96 : 647 55.
21. Vakil N, van Zanten SV, Kahrilas P, et al. and the Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus. Am J Gastroenterol 2006 101 : 1900 20.
22. Zentilin P, Iiritano E, Dulbecco P, et al. Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis 2006 38 : 226 32.
23. Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: Review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004 53 : 1024 31.
24. Mattox HE, Richter JE. Prolonged ambulatory esophageal pH monitoring in the evaluation of gastroesophageal reflux disease. Am J Med 1990 89 : 345 56.
25. Pace F, Annese V, Ceccatelli P, et al. Ambulatory oesophageal pH-metry. Position paper of the working team on oesophageal pHmetry by the GISMAD (Gruppo Italiano di Studio sulla Motilita' dell'Apparato Digerente). Dig Liver Dis 2000 32 : 357 64.
26. Weusten BL, Roelofs JM, Akkermans LM, et al. The symptom-association probability: An improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994 107 : 1741 5.
27. Bredenoord AJ, Weusten BL, Smout AJ. Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut 2005 54 : 1810 7.
28. Zentilin P, Conio M, Mele R, et al. Comparison of the main oesophageal pathophysiological characteristics between short- and long-segment Barrett's oesophagus. Aliment Pharmacol Ther 2002 16 : 893 8.
29. Fox M, Barr C, Nolan S, et al. The effects of dietary fat and calorie density on esophageal acid exposure and reflux symptoms. Clin Gastroenterol Hepatol 2007 5 : 439 44.
30. Shapiro M, Green C, Bautista JM, et al. Assessment of dietary nutrients that influence perception of intra-oesophageal acid reflux events in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007 25 : 93 101.
31. El-Serag HB, Satia JA, Rabeneck L. Dietary intake and the risk of gastro-oesophageal reflux disease: A cross sectional study in volunteers. Gut 2005 54 : 11 7.
32. Nocon M, Labenz J, Willich SN. Lifestyle factors and symptoms of gastroesophageal reflux - a population-based study. Aliment Pharmacol Ther 2006 23 : 169 74.
33. Nebel OT, Castell DO. Inhibition of the lower esophageal sphincter by fat - a mechanism for fatty food intolerance. Gut 1973 14 : 270 4.
34. Becker DJ, Sinclair J, Castell DO, et al. A comparison of high and low fat meals on postprandial esophageal acid exposure. Am J Gastroenterol 1989 84 : 782 6.
35. Murphy DW, Castell DO. Chocolate and heartburn: Evidence of increased esophageal acid exposure after chocolate ingestion. Am J Gastroenterol 1988 83 : 633 6.
36. Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1892 307 : 1547 52.
37. Iwakiri K, Kobayashi M, Kotoyori M, et al. Relationship between postprandial esophageal acid exposure and meal volume and fat content. Dig Dis Sci 1996 41 : 926 30.
38. Mittal RK, Holloway RH, Penagini R, et al. Transient lower esophageal sphincter relaxation. Gastroenterology 1995 109 : 601 10.
39. Klauser AF, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990 335 : 205 8.
40. Kahrilas PJ. Review article: Gastro-oesophageal reflux disease as a functional gastrointestinal disorder. Aliment Pharmacol Ther 2004 20 (Suppl 7 50 5.
41. Tack J, Janssens J. Functional heartburn. Curr Treat Options Gastroenterol 2002 5 : 251 8.
42. Vela M, Camacho-Lobato L, Srinivasan R, et al. Simultaneous intraoesophageal impedance and ph measurement of acid and nonacid gastroesophageal reflux: Effect of omeprazole. Gastroenterology 2001 120 : 1599 606.
43. Emerenziani S, Sifrim D, Habib FI, et al. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Gut 2008 57 : 443 7.
44. Lam HG, Breumelhof R, van Berge Henegouwen GP, et al. Temporal relationships between episodes of noncardiac chest pain and abnormal oesophageal function. Gut 1994 35 : 733 6.
45. Mainie I, Tutuian R, Shay S, et al. Acid and nonacid reflux in patients with persistent symptoms despite acid suppressive therapy. A multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006 55 : 1398 402.
46. Bredenoord AJ, Weusten BL, Curvers WL, et al. Determinants of perception of heartburn and regurgitation. Gut 2006 55 : 313 8.
47. Zerbib F, Roman S, Ropert A, et al. Esophageal pH-monitoring and symptom analysis in GERD - a study in patients off and on PPI therapy. Am J Gastroenterol 2006 101 : 1956 63.
48. Mainie I, Tutuian R, Agrawal A, et al. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006 93 : 1483 7.